Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)

被引：69
|
作者：
Dresser, MJ
Xiao, GQ
Leabman, MK
Gray, AT
Giacomini, KM [1 ]
机构：
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA
来源：
PHARMACEUTICAL RESEARCH | 2002年 / 19卷 / 08期
关键词：
transporter; organic cation; selectivity; metformin; phenformin;
D O I：
10.1023/A:1019870831174
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1244 / 1247
页数：4
相关论文
共 50 条
  • [41] Expression levels of hOCT2 and renal excretion of N1-methylnicotineamide in patients with renal disease
    Motohashi, Hideyuki
    Kishimoto, Koshiro
    Katsura, Toshiya
    Inui, Ken-ichi
    Fukatsu, Atsushi
    DRUG METABOLISM REVIEWS, 2006, 38 : 159 - 159
  • [42] High glucose increases transport capacities of the human organic cation transporters hOCT1 and hOCT2 and of the human multidrug and toxin extrusion transporter hMATE1 expressed in HEK293 cells
    Menne, J.
    Steinbuecel, M.
    Ciarimboli, G.
    Schlatter, E.
    ACTA PHYSIOLOGICA, 2016, 216
  • [43] Renal handling and toxicity of platinum agents determined by organic cation transporters, hOCT2, hMATE1 and hMATE2-K
    Yonezawa, Atsushi
    Yokoo, Sachiko
    Masuda, Satohiro
    Katsura, Toshiya
    Inui, Ken-ichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 53 - 54
  • [44] Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)
    Bourdet, DL
    Pritchard, JB
    Thakker, DR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1288 - 1297
  • [45] Neurotransmitter transport mediated by two members (rOCT1 and hOCT2) of the cation transporter family OCT.
    Quester, S
    Baumann, C
    Ulzheimer, JC
    Gorboulev, V
    Akhoundova, A
    Waldegger, S
    Ruppersberg, JP
    Lang, F
    Koepsell, H
    Busch, AE
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1997, 433 (06): : O95 - O95
  • [46] Impairment of clofarabine (CLO) clearance (CL) in the presence of cimetidine: Evidence of a drug-drug interaction between clofarabine and inhibitors of human organic cation transporter-2 (hOCT2)
    Foster, Matthew C.
    Walko, Christine
    Kumar, Parag
    Huang, Jeffrey
    Ivanova, Anastasia
    Garcia, Reynaldo
    Van Deventer, Hendrik
    Ewesuedo, Reginald
    Shea, Thomas C.
    CANCER RESEARCH, 2012, 72
  • [47] The expression of the human organic cation transporter hOCT1 in mammary gland.
    Dhillon, U
    Shenton, J
    Cook, V
    Harper, P
    Watson-Macdonell, J
    Ito, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 205 - 205
  • [48] Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1)
    Moaddel, R.
    Ravichandran, S.
    Bighi, F.
    Yamaguchi, R.
    Wainer, I. W.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (08) : 1305 - 1314
  • [49] Tissue specific expression of variants of the human organic cation transporter (hOCT1)
    Hayer, M
    Brüss, M
    Bönisch, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R413 - R413
  • [50] The function and expression of the human organic cation transporter hOCT1 in mammary gland
    Dhillon, U
    Cook, V
    Harper, P
    Watson-MacDonell, J
    Ito, S
    FASEB JOURNAL, 1999, 13 (04): : A402 - A402
12345